gene therapy

Novartis' SMA gene therapy would not be cost-effective if priced over $1.5M: ICER
Fierce Pharma
Thu, 04/4/19 - 11:54 am
Novartis
ICER
drug pricing
Zolgensma
gene therapy
spinal muscular atrophy
Does Sangamo Have the Best Gene Therapy Program Now?
Motley Fool
Wed, 04/3/19 - 12:28 pm
Sangamo Therapeutics
gene therapy
SB-525
hemophilia A
Roche must ask Spark shareholders once again to sell
Biopharma Dive
Wed, 04/3/19 - 12:23 pm
Roche
Spark Therapeutics
gene therapy
M&A
2 Blockbuster Gene Therapy Programs to Watch in 2019
Motley Fool
Sun, 03/31/19 - 03:42 pm
gene therapy
Zolgensma
Novartis
Bluebird Bio
LentiGlobin
Takeda takes a cautious step into neurological gene therapy, inking preclinical deal with StrideBio
Endpoints
Sat, 03/30/19 - 12:10 am
Takeda
StrideBio
gene therapy
First gene therapy to treat rare blood disease nears European approval
Stat
Fri, 03/29/19 - 10:05 am
Bluebird Bio
Europe
LentiGlobin
gene therapy
beta-thalassemia
Gene therapy company Prevail raises $50M series B
BioCentury
Wed, 03/27/19 - 11:39 pm
Prevail Therapeutics
gene therapy
neurodegenerative disease
Bluebird opens manufacturing facility as it moves gene therapies forward
Fierce Pharma
Tue, 03/26/19 - 11:39 am
Bluebird Bio
gene therapy
cell therapy
drug manufacturing
Thermo Bags Brammer For $1.7B as Gene Therapy Deal Spree Continues
Xconomy
Mon, 03/25/19 - 10:27 am
Thermo Fisher
Brammer Bio
M&A
gene therapy
bluebird bio to Cut Ribbon on New Gene Therapy Factory in Durham, NC; Plans to Hire
BioSpace
Fri, 03/22/19 - 10:06 pm
Bluebird Bio
gene therapy
drug manufacturing
bb2121
bb21217
LentiGlobin
Pfizer buys stake in French gene therapy firm Vivet
CNBC
Wed, 03/20/19 - 09:57 am
Pfizer
M&A
Vivet
gene therapy
liver disease
Gene therapy progress spurs competition in biotech buyouts
Biopharma Dive
Tue, 03/19/19 - 11:41 pm
biotech
gene therapy
M&A
Biogen
Nightstar Therapeutics
Roche
Spark Therapeutics
Partnering talks led to Biogen’s $800M Nightstar buyout as players clustered around the hot deal table for gene therapies
Endpoints
Mon, 03/18/19 - 11:48 pm
Biogen
gene therapy
Nightstar Therapeutics
M&A
Call For CRISPR Moratorium Echoes Early Days Of Gene Therapy
Forbes
Sat, 03/16/19 - 12:29 pm
gene therapy
gene editing
CRISPR
Microsoft partners with biotech on ‘biological computing’ and cell DNA programming
Fierce Biotech
Tue, 03/12/19 - 06:30 pm
Microsoft
DNA
DNA programming
gene therapy
Axovant trumpets new clinical data after gene therapy pivot
Fierce Biotech
Mon, 03/11/19 - 10:11 pm
Axovant
gene therapy
Parkinson's Disease
Tay Sachs
[video+transcript]Gene Therapy M&A Has Shares Skyrocketing -- Could This Company Be Next?
Motley Fool
Sat, 03/9/19 - 12:11 pm
gene therapy
M&A
Rengexbio
Biogen to acquire ophthalmology gene therapy play Nightstar
BioCentury
Mon, 03/4/19 - 10:37 am
Biogen
M&A
Nightstar Therapeutics
gene therapy
ophthalmology
After J&J retinal deal, MeiraGTx raises $80M for unpartnered programs
BioCentury
Wed, 02/27/19 - 07:16 pm
MeiraGTx
JNJ Innovation
gene therapy
retinal disease
Gene Therapy Market Heats up as Sarepta Buys Myonexus for $165 Million
BioSpace
Wed, 02/27/19 - 10:57 am
Sarepta Therapeutics
gene therapy
M&A
Myonexus

Pages